Clinical Trial Update: Relationship Between FGF19 Overexpression and Disease Prognosis

View source ↗

Summary

The trial examines whether FGF19 overexpression influences prognosis in hepatocellular carcinoma. Recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Status: NOT_YET_RECRUITING